{"disease":{"id":"brest-cancer","name":"brest cancer"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06717295","title":"The CCANED-CIPHER Study: Early Cancer Detection and Treatment Response Monitoring Using AI-Based Platelet and Immune Cell Transcriptomic Profiling","phase":"","overall_status":"RECRUITING","enrollment_count":6000,"lead_sponsor_name":"Javier Toledo","has_results":false},{"nct_id":"NCT07491055","title":"Wide-Angle Tomosynthesis and AI in Diagnostic Mammography","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":1400,"lead_sponsor_name":"Jean Seely","has_results":false},{"nct_id":"NCT07493291","title":"Effectiveness and Safety of Palbociclib: Brand vs. Generic in Iraqi Stage IV Breast Cancer Patients","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":100,"lead_sponsor_name":"Al-Mustansiriyah University","has_results":false},{"nct_id":"NCT06820554","title":"Thyroid Dysfunction Induced by Radiotherapy Treatment in Patients with Breast Cancer","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":97,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT07333937","title":"Neratinib Combined With Fulvestrant and Eribulin in the Treatment ofHR+/HER2+ Advanced Breast Cancer","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":35,"lead_sponsor_name":"Xijing Hospital","has_results":false},{"nct_id":"NCT06621459","title":"Retrospective Observational Study of the Safety and Toxicity Management of Abemaciclib in Combination with Adjuvant Hormone Therapy in Patients with RH+ ,HER2-nonoveramplified Breast Cancer, Real-life Data (MONARCHE29)","phase":"","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"University Hospital, Brest","has_results":false}],"total":6},"guidelines":[],"source":"Drug Landscape verified database"}